山东省治疗癫痫需要多少钱江苏癫痫病医院收费,全国那家看癫痫病安全,潍坊癫痫病治疗方法,山东省治疗宜昌哪家医院好,山东癫痫病看癫痫哪个好,山东癫痫怎样治效果好,日照好治疗医院羊羔疯专病

SAN FRANCISCO, Dec. 15 (Xinhua) -- Microsoft on Thursday announced that it will automatically upgrade the Internet Explorer (IE) to the latest version to give Windows customers more protection against malicious software.According to the company's blog post, starting from Australia and Brazil next January, users of Windows XP, Vista and Windows 7 will get the IE updates if they have turned on automatic updating via Windows Update.Microsoft said the industry has been moving toward automatic updates as a norm since the biggest online threat these days is social engineering malware typically targeting outdated software like Web browsers.Automatic upgrades, also called silent updates for displaying no messages or windows during the progress, has been deployed by Google's Chrome and Mozilla's Firefox. It can ensure users have the newest versions of the browser, and therefore is seen as a big improvement to Internet security.According to the Microsoft Security Intelligence Report released in October, 99 percent of all attacks during the first half of 2011 came from unpatched but known vulnerabilities, and 90 percent of infections were attributed to vulnerability exploitation that had a security update available from the software vendor for more than a year.In the latest research data from Web analytics company StatCounter, Microsoft's IE has a strong lead with 40.63 percent of global browser market share, followed by 25.7 percent of Chrome and 25.23 percent of Firefox.

BEIJING, Nov. 16 (Xinhua) -- A senior Chinese commerce official said on Wednesday that the country will work to optimize the import mix of mechanical and electronic products so they can play a bigger role in China's restructuring efforts.Li Jinzao, vice minister of the Ministry of Commerce, made the remarks at a forum of the ongoing 13th "China Hi-Tech Fair" in Shenzhen.His remarks echoed a guideline issued in March on promoting the imports of mechanical and electronic products during the 2011-2015 period, in which China pledged efforts to encourage the imports of high-tech products.Li said that China will improve existing policies to attach more importance to the imports of advanced technology, equipment and components to spur innovation.Meanwhile, he said China will organize more trading events to exchange and cooperate with international businesses, and will continue to push the United States and European countries to ease restrictions on civil high-tech exports to China.

BEIJING, Jan. 9 (Xinhua) -- China's official website for booking train tickets received a daily average of more than 1 billion hits during the first week of January, according to a railway official.Hu Yadong, vice minister of railways, said Sunday that the online ticket sales platform has provided consumers with a convenient way to buy tickets. He also addressed complaints about the fairness of the sales process."Train tickets sold online or by telephone have topped 2 million daily, meaning that around one-third of passengers don't have to wait in line at train stations for several hours to get a ticket," Hu said.However, many Chinese have expressed dissatisfaction with the website, with some people unable to get train tickets home for this year's Spring Festival holiday, a major holiday in China.Several customers posted their complaints on popular microblogging website weibo.com, stating that the booking site often failed due to "too many visits at the same time."The Spring Festival holiday is always a difficult time for China's public transportation authorities. A total of 3.16 billion passenger trips are expected during the holiday, up 9.1 percent from a year earlier, of which 235 million trips will be made via the country's railways, up 6.1 percent year-on-year, said Hu.This year's transport rush in the Spring Festival Season started on Sunday and will end on Feb. 16, according to the Ministry of Railways.

WASHINGTON, Oct. 13 (Xinhua) -- In a trial that included about 35,000 men, those who were randomized to receive daily supplementation with vitamin E had a significantly increased risk of prostate cancer, according to a study published this week in the Journal of the American Medical Association.The study followed more than 35,533 men 50 or older at 427 sites in the United States, Canada and Puerto Rico. The men were divided into four groups who took daily doses of 400 international units of Vitamin E and 200 micrograms of selenium; Vitamin E and a placebo that looked like selenium; selenium and a placebo that looked like Vitamin E; or two placebos. The recommended daily intake of Vitamin E is about 22.4 international units.The researchers from the Cleveland Clinic found that the rate of prostate cancer detection was greater in all treatment groups when compared with placebo but was statistically significant only in the vitamin E alone group -- a 17 percent increased rate of prostate cancer detection. The difference in rates of prostate cancer between vitamin E and placebo became apparent during the participants' third year in the trial. The elevated risk estimate for vitamin E was consistent across both low- and high-grade disease."The observed 17 percent increase in prostate cancer incidence demonstrates the potential for seemingly innocuous yet biologically active substances such as vitamins to cause harm. The lack of benefit from dietary supplementation with vitamin E or other agents with respect to preventing common health conditions and cancers or improving overall survival, and their potential harm, underscore the need for consumers to be skeptical of health claims for unregulated over-the-counter products in the absence of strong evidence of benefit demonstrated in clinical trials," the researchers said.

WASHINGTON, Nov. 24 (Xinhua) -- An inexpensive drug that treats Type 2 diabetes has been shown to prevent a number of natural and man-made chemicals from stimulating the growth of breast cancer cells, according to a newly published study by a Michigan State University researcher. The research, led by pediatrics professor James Trosko and colleagues from South Korea's Seoul National University, provides biological evidence for previously reported epidemiological surveys that long-term use of the drug metformin for Type 2 diabetes reduces the risk of diabetes-associated cancers, such as breast cancers.The research appeared online this week in PLoS One.For the study, Trosko and colleagues focused on the concept that cancers originate from adult human stem cells and that there are many natural and man-made chemicals that enhance the growth of breast cancer cells. Using culture dishes, they grew miniature human breast tumors, or mammospheres, that activated a certain stem cell gene. Then the mammospheres were exposed to natural estrogen -- a known growth factor and potential breast tumor promoter -- and man-made chemicals that are known to promote tumors or disrupt the endocrine system.The team found that estrogen and the chemicals caused the mammospheres to increase in numbers and size. However, with metformin added, the numbers and size of the mammospheres were dramatically reduced. While each of the chemicals enhanced growth by different means, metformin seemed to be able to inhibit their stimulated growth in all cases."While future studies are needed to understand the exact mechanism by which metformin works to reduce the growth of breast cancers, this study reveals the need to determine if the drug might be used as a preventive drug and for individuals who have no indication of any existing cancers," Trosko said.